Human gene therapy and imaging in neurological diseases

被引:14
|
作者
Jacobs, Andreas H. [1 ,2 ,3 ]
Winkler, Alexandra [1 ,2 ,3 ]
Castro, Maria G. [4 ,5 ]
Lowenstein, Pedro [4 ,5 ]
机构
[1] MPI Neurol Res, Lab Gene Therapy & Mol Imaging, D-50931 Cologne, Germany
[2] Univ Cologne, Max Planck Inst Neurol Res, Ctr Mol Med CMMC, Cologne, Germany
[3] Univ Cologne, Dept Neurol, Cologne, Germany
[4] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90048 USA
[5] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA
关键词
molecular imaging; FIAU; FHBG; PET; glioma; Parkinson's disease;
D O I
10.1007/s00259-005-1960-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Molecular imaging aims to assess non-invasively disease-specific biological and molecular processes in animal models and humans in vivo. Apart from precise anatomical localisation and quantification, the most intriguing advantage of such imaging is the opportunity it provides to investigate the time course (dynamics) of disease-specific molecular events in the intact organism. Further, molecular imaging can be used to address basic scientific questions, e.g. transcriptional regulation, signal transduction or protein/protein interaction, and will be essential in developing treatment strategies based on gene therapy. Most importantly, molecular imaging is a key technology in translational research, helping to develop experimental protocols which may later be applied to human patients. Over the past 20 years, imaging based on positron emission tomography (PET) and magnetic resonance imaging (MRI) has been employed for the assessment and "phenotyping" of various neurological diseases, including cerebral ischaemia, neurodegeneration and brain gliomas. While in the past neuro-anatomical studies had to be performed post mortem, molecular imaging has ushered in the era of in vivo functional neuro-anatomy by allowing neuroscience to image structure, function, metabolism and molecular processes of the central nervous system in vivo in both health and disease. Recently, PET and MRI have been successfully utilised together in the non-invasive assessment of gene transfer and gene therapy in humans. To assess the efficiency of gene transfer, the same markers are being used in animals and humans, and have been applied for phenotyping human disease. Here, we review the imaging hallmarks of focal and disseminated neurological diseases, such as cerebral ischaemia, neurodegeneration and glioblastoma multiforme, as well as the attempts to translate gene therapy's experimental knowledge into clinical applications and the way in which this process is being promoted through the use of novel imaging approaches.
引用
收藏
页码:S358 / S383
页数:26
相关论文
共 50 条
  • [1] Human gene therapy and imaging in neurological diseases
    Andreas H. Jacobs
    Alexandra Winkler
    Maria G. Castro
    Pedro Lowenstein
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : S358 - S383
  • [2] Human gene therapy and imaging in neurological diseases
    Andreas H. Jacobs
    Alexandra Winkler
    Maria G. Castro
    Pedro Lowenstein
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 390 - 390
  • [3] Human gene therapy and imaging in neurological diseases (vol 32, pg S358, 2005)
    Jacobs, AH
    Winkler, A
    Castro, MG
    Lowenstein, P
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (03) : 390 - 390
  • [4] Prospects of treating neurological diseases by gene therapy
    Lundstrom, Kenneth
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (01) : 34 - 40
  • [5] Non invasive gene therapy in neurological diseases
    Brito-Armas, Jose M.
    Castro-Hernandez, Javier
    Rodriguez-Diaz, Manuel
    Castro-Fuentes, Rafael
    [J]. REVISTA DE NEUROLOGIA, 2011, 52 (10) : 603 - 617
  • [6] Recent Gene Therapy Advancements for Neurological Diseases
    Kalburgi, Sahana Nagabhushan
    Khan, Nadia N.
    Gray, Steven J.
    [J]. DISCOVERY MEDICINE, 2013, 15 (81) : 111 - 119
  • [7] Human Neural Stem Cell-Based Cell and Gene Therapy for Neurological Diseases
    Kim, S. U.
    [J]. CELL TRANSPLANTATION, 2012, 21 (04) : 784 - 784
  • [8] PET molecular imaging in stem cell therapy for neurological diseases
    Wang, Jiachuan
    Tian, Mei
    Zhang, Hong
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (10) : 1926 - 1938
  • [9] PET molecular imaging in stem cell therapy for neurological diseases
    Jiachuan Wang
    Mei Tian
    Hong Zhang
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1926 - 1938
  • [10] Molecular Imaging in Traditional Chinese Medicine Therapy for Neurological Diseases
    Wang, Zefeng
    Wan, Haitong
    Li, Jinhui
    Zhang, Hong
    Tian, Mei
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013